Cardiopulmonary Exercise for Congenital Heart Disease
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Cardiopulmonary exercise testing is a valuable tool for assessing patients with congenital heart disease, as it helps evaluate their exercise capacity and identify any heart or lung issues. This testing can guide treatment decisions and improve management of the condition, suggesting that related procedures like cardiac catheterization and angiography may also be beneficial in understanding and treating congenital heart disease.
12345Exercise training, including cardiopulmonary exercise, is generally considered safe for children and adolescents with congenital heart disease, as it can help improve their health and manage their condition.
14678Cardiac catheterization is unique because it involves inserting a thin tube into a blood vessel to diagnose or treat heart conditions, providing direct access to the heart and blood vessels. This approach is different from other treatments that might rely on external imaging or medication, as it allows for precise intervention and assessment of the heart's function.
124910Eligibility Criteria
This trial is for individuals with heart disease, specifically congenital heart defects. Participants should be able to perform exercise as part of the study but specific inclusion and exclusion criteria are not provided.Inclusion Criteria
Exclusion Criteria
Participant Groups
- Diagnosis of coronary artery disease
- Assessment of cardiac function
- Evaluation of heart valve disorders
- Diagnosis of coronary artery disease
- Assessment of cardiac function
- Evaluation of heart valve disorders
- Preoperative evaluation for cardiac surgery
- Diagnosis of coronary artery disease
- Assessment of cardiac function
- Evaluation of heart valve disorders
- Diagnosis of coronary artery disease
- Assessment of cardiac function
- Evaluation of heart valve disorders